Br J Clin Pharmacol 2004;57:44855
Continuous education ensures that both parties are equipped with the knowledge needed to manage risks effectively
Your cart is empty Hasan Mirza, MD Thank you You are now being directed to the checkout page.

CrossRef Therapeutic modulation of the gut-liver axis with faecalibacterium prausnitzii in metabolic dysfunction-associated steatohepatitis Han Chen, Yan Wang, Wei Su, Yicheng Liu, Shuo Li, Yun Liu, Xiaoying Zhou BMC Microbiology .2026;[Epub] CrossRef MetALD at the crossroads of metabolic and alcohol-related liver disease Gustavo Ayares, Luis Antonio Daz, Juan Pablo Arab, Marco Arrese Trends in Endocrinology & Metabolism .2026;[Epub] CrossRef Prebiotic modulation of FMT donor microbiota enhances MASLD-relevant taxa and functions in an in vitro gut model Kait F Al, Suyang Jia, Michael Silverman, Gregor Reid, Jeremy P Burton, Seema Nair Parvathy Journal of Applied Microbiology .2026;[Epub] CrossRef Association of gut microbiota dietary index with MAFLD and the risk of liver fibrosis: the mediating effect of vitamins Jinlu Han, Teng Zhou, Jiong Chen, Ling Xu, Wen Shan, Qinghui Zhang Journal of Nutritional Science .2026;[Epub] CrossRef The MicrobiomeGutLiver Axis Drives PostKasai Fibrosis in Biliary Atresia: From Mechanism to Precision Intervention Jiwen Cheng Hepatology Research .2026
